Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
| Image |  |
|---|---|
| Description | scientific article published on 01 October 2018 |
| Author/s |
author: Lucjan S Wyrwicz |
| Publication date | October 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |